Everest Organics Ltd Q1FY22 PAT lower at Rs 2 13 crore equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.
Read more about Everest Organics standalone net profit declines 44.44% in the March 2021 quarter on Business Standard. Sales decline 2.70% to Rs 45.04 crore
Everest Organics hit an upper circuit of 20% at Rs 399.50 after the company announced the successful development of an anti-fungal API (active pharmaceutical ingredient) Posaconazole meant to treat black fungus patients.
The anti-fungal API has been developed at the lab scale in the existing R&D facility of Everest Organics.
Posaconazole is a triazole antifungal agent indicated for treating mucormycosis patients popularly known as Black Fungus in post-COVID complications.
Dr. Srikakarlapudi Sirisha, director, commenting on this recent development stated: The Everest Organics has successfully developed the API Posaconazole using its own in-house R&D strength at lab scale in short span of time. Further, we are in advance stage of commercializing the same.
Shares of Everest Organics hit a 20 per cent upper circuit limit of Rs 399.50, also its record high on the BSE in Tuesday s session after the company announced a successful development of Posaconazole API (Active Pharmaceutical Ingredient) used for the treatment of Black Fungus. The trading volumes on the counter jumped nearly 10-fold with around 76,000 equity shares having changed hands on the BSE, as against an average sub 8,000 shares that were traded in the past two weeks. There were pending buy orders for 24,195 shares, the exchange data shows. Posaconazole is a triazole antifungal agent indicated for treating mucormycosis, popularly known as Black Fungus, as part of post-Covid complications. The company is in the advanced stage of commercializing the same, Everest Organics said in a press release.
Everest Organics Limited launches Posaconazole API equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.